PHARMARON — —
  • 中金公司看好创新药产业链：短期回调不改中长期崛起趋势

    中金公司发布2026年下半年生物医药展望，指出创新药板块虽受宏观环境、流动性轮转等因素影响进入短期估值回调阶段，但license out和new co等国际化路径持续验证，国内外投融资回暖为CXO上游产业带来明确订单增量，中长期崛起趋势不改。

📊 在监控面板里跟踪 PHARMARON —— 添加到 watchlist，配合价格 + 舆情双触发的告警规则，命中即时通过 Telegram / 邮件推送。

🗂️ All Tools

RedianPro one-stop tool index — 22 dedicated function pages. Data auto-refreshes every 30 min to 1 hour.

📋BriefingTonight's pre-market read📰Daily WrapWhat happened today🌡️Sectors11 SPDR sector ETFs📅Earnings14d earnings + FOMC📝InsidersSEC Form 4 ≥ $1M🏛️Fed MacroFOMC + Fed speeches📈Yield Curve11 tenors + inversion📊CFTC COTHedge fund positioning₿Crypto12 coins + Fear/Greed⛽CommoditiesGold / Oil / Ag🐉China ADRsADR ⇆ HK arb🔥WSB HeatRetail social Top 50🏆LeaderboardMost-watched tickers🚀52w HighMomentum signals📉52w LowReversal candidates🔎ScreenerMulti-dim filter⚖️Compare30 metrics side-by-side🧮CalculatorsDCF / IV / Sharpe🤖AI Q&ANatural language query🔍SearchSite-wide search📚Glossary100+ EN-CN terms📈PortfolioClient-side simulator📑NewsDaily Chinese digest